Chronic Diseases, avoid the 5 BIG killers!: Cancers, Cardio-Vasculars, Dementias, Diabetes, Depressions. (Very Very Healthy Book 1) Kindle Edition
This book presents information which makes it possible to avoid the vast majority of diseases, and can be followed with confidence, since it comes from health professionals and scientific researchers.
This book integrates essential data from more than 25 different books, which I encourage you to buy and read in full, of which 19 authors are medical practicing doctors, 6 are doctors of science (PhD), and 2 are graduate nutritionists and dietitians working in hospitals.
I wanted to integrate more books written by women doctors, but I could not find the books that corresponded to the purpose of this book.
I started with a review of hundreds of books on the subject of health, I selected more than 150, including 90 written by doctors, and only then did I choose in priority those which had the greatest potential to save lives and bring people back to good health, while being written by medical professionals. In addition to these books, which already exceed 7,000 pages, other information comes from publications by other doctors who have not written books.
This book therefore deals with the main causes of current mortality and suffering. For each case I show the information and statistics presented on the official websites, then I share the information from several books of doctors who explain where the problems come from, and what to do to avoid them.
And after a conclusion in three parts, I kept the last pages of the book for suggestions on taking action, so that this section is easily accessible in everyday life, the time to integrate the different elements.
From the 1940s to the 1960s, doctors went to observe the populations of non-modernized countries on all continents. Their conclusion was that these populations had no cardiovascular problems, no cancers, no diabetes, no dementia, while these chronic diseases were already developing massively in more industrialized and urban countries. Then they found that these healthy people, when they migrated to a modern country, started to develop these chronic diseases. It was already proof that these ailments were not hereditary or genetic, but only due to the environment in which the person lived. Air pollution was still quite low compared to today, there were far fewer people on Earth, and fewer industries, polluting vehicles, and therefore there were two possible factors to cause these diseases, food or sedentary lifestyle, or both at the same time.
It had therefore been discovered that healthy humans eat large quantities and varieties of plant products, and animal products in limited quantities. It is generally not by ethical or taste choice, but simply because the environment in which we live determines what is available to us as a source of food. For millennia we had easy access to many vegetable products at hand, fruits and vegetables of all kinds, which we ate without overcooking them, and animal products were more difficult to access. Today it is very different, in industrialized countries we have all kinds of cheap animal products available, while fruits and vegetables are more expensive and difficult to find. In addition, we have developed all kinds of cooking habits to enrich our palette of flavors, to the detriment of the beneficial molecules present in fresh products.
The most dramatic for our body is certainly the trivialization of very industrially processed products, which are empty of beneficial micronutrients, but which in addition contain molecules indigestible by our microbial flora, which cause chronic inflammations in our intestines, which ends up unbalancing our whole organism. It is food from which our body cannot extract anything useful, but which in addition ends up becoming harmful and making us sick.
Our cells are very complicated organisms that need hundreds of different molecules to function properly. Likewise for our microbiota, which is responsible for producing many molecules that we need, but which also needs varied and specific food.
FOR IMMEDIATE RELEASE Orthomolecular Medicine News Service, October 20, 2020
Commentary by W. Gifford-Jones, MD
(OMNS Oct 20, 2020) In treating the sick, Hippocrates, the Father of Medicine counselled, “First, do no harm.” Unfortunately, this cherished principle has not been followed in caring for patients with coronavirus infection. Losing a loved one due to cancer and other diseases is always tragic. But losing one due to the coronavirus pandemic when it could be prevented is an unforgivable act resulting in the mass murder of innocent lives. It has happened due to ignorance about history, hypocrisy, a lack of training of doctors about alternative medicine, and closed minds about the life-saving medical benefits of high doses of intravenous vitamin C.
I would not have the knowledge to write this article if one event in my life had not happened. At 74 years of age I nearly died of a serious heart attack. Doctors said I’d be dead in a few years without the help of cholesterol-lowering drugs. Luckily, many years earlier I had interviewed Dr. Linus Pauling, two-time winner of the Nobel Prize. He advised me of the important role of vitamin C in decreasing the risk of coronary disease. This is when I made one of the most vital decisions of my life. I decided to take 10,000 milligrams (mg) of vitamin C daily, rather than believe Big Pharma. But I also worried because Pauling, although a brilliant chemist, was not a doctor. Was he right about vitamin C? It was only years later when Dr. Sidney Bush, a English researcher proved that vitamin C could reverse atherosclerosis (hardening of arteries) that I knew I had made the right decision. 
Now, 22 years later, the doctors who told me I’d be dead in a few years without cholesterol-lowering drugs are dead, and I’m in my 97th year, still alive. It’s this experience with the cardiovascular effects of vitamin C that’s triggered my interest in the anti-infective and other medical benefits of vitamin C, especially how it can decrease deaths from viral and bacterial diseases.
Klenner went on to show that large doses of vitamin C could also cure other viral diseases such as meningitis, hepatitis, measles, mumps, pneumonia, shingles and even the poisonous bite of a rattlesnake. [2-4] Since that time other researchers have reported that there is no viral disease that high-dose IVC cannot successfully treat.
But Klenner did not win a popularity contest with his colleagues. He wrote in frustration that “Some physicians would stand by and see their patient die rather than use ascorbic acid because in their finite minds it exists only as a vitamin.”
Since that time closed medical minds have resulted in thousands of deaths from coronavirus and other diseases in Canada and worldwide. Because of a misconception that vitamin C is just another vitamin. But there is proof that vitamin C is a potent anti-infective nutrient that attacks both viral and bacterial diseases.
Infection triggers a severe inflammatory cellular reaction in the body which results in a decrease in vitamin C. It’s like being caught in a snow storm on a lonely road and running out of gas. But in this case white blood cells need C to fight the infection. And if you have not been taking C on a regular basis, your white blood cells without C are like a gun without bullets.
Many people do not realize that nearly all animals make their own vitamin C. Humans lost this ability eons ago due to a genetic mutation. For instance, dogs produce 5,000 milligrams (mgs) daily. Health Canada maintains humans need only 90 mgs. But if a dog gets an infection, it will automatically produce up to 20,000 mgs daily!
During the coronavirus pandemic I’ve listened to Medical Officers of Health, TV anchors, politicians and medical experts all discuss the importance of distancing and frequent hand washing. But I have only heard one discuss the advantages of vitamin C and D in building up the body’s immunity.  And I have not heard any explain how the use of high doses of IVC could save lives.
Dr. Lendon H. Smith outlined the clinical experiences of Frederick Klenner in “Clinical Guide to the Use of Vitamin C”. It contains a wealth of information on how vitamin C treats many diverse diseases. And how prescribing insufficient amounts of vitamin C can lead to failure in therapy. This medical information is available for all to read. 
I’ve have written before that if a family member died due to coronavirus infection and doctors and hospital refused to use IVC, I would contest this situation in a court of law. I believe I would win because historical evidence is so overwhelming that large doses of C save lives.
The hypocrisy surrounding vitamin C is mind boggling. Dr, Linus Pauling complained, “The medical community requires rigorous evidence supporting vitamin C, but accepts flimsy evidence against it.” Little has changed since I interviewed Pauling. This deficit is evidently caused by the minds of medical professionals refusing to accept scientific fact. And we will never know the number of needless deaths this has caused during the pandemic.
A year ago, as a journalist, I was invited to be a member of the Orthomolecular Medical News Service. It’s international editorial board is composed of distinguished physicians, professors, and researchers. Several months ago I asked all members how they would treat several viral infections. The overwhelming response was “high dose intravenous vitamin C.” OMNS has published twenty-two physician case reports of success with IVC. 
Since February, researchers in China have been conducting double-blind studies on IVC. This means one group will receive IVC and a control group will get a placebo. Some studies have already been completed, and the results show that IVC saves more lives than placebo. 
“Dr. Enqiang Mao, chief of emergency medicine at Ruijin Hospital, Shanghai, stated that his group treated ~50 moderate to severe cases of COVID-19 infection with high dose intravenous vitamin C. “The IVC dosing was for 7-10 days, with 10,000 mg for moderate cases and 20,000 mg for more severe cases.
“All patients who received intravenous vitamin C improved, and there was no mortality.”
“There were no side effects reported from any of the cases treated with high dose IVC.”
But even in one of these recent laudable studies, there was a flaw. According to the report, all patients received a certain dose for moderate infection while others a higher dose for a more severe one. But patients who died had not received the higher dose. 
This reflects everything that Dr. Linus Pauling and Dr. Frederick Klenner stressed. As Pauling told his critics, “It’s the dosage!” Or, as Klenner claimed, “Some infections require a much larger dose.” As we all know, half an aspirin will not cure a migraine headache.
But there is more disturbing news. Chinese researchers are experiencing trouble getting their findings published. Contacts also tell me that doctors who use IVC in North America are being harassed by authorities. In some case, being told that if they persist they will lose their license to practice medicine.
To get an update on what was happening in some parts of Canada and the U.S I contacted several infectious disease specialists, Medical Officers of Health (MOH), and university hospitals, asking a simple question. “Do you prescribe intravenous vitamin C or know of anyone who does to treat coronavirus infection? And if terminal patients are not receiving IVC, why is this the case”?
It proved to be a time-consuming assignment. Many replied they would get back to me but failed to do so. I could only conclude they were not using IVC and did not want anyone to know about it.
Or they responded, “We have checked with our infectious disease specialist and confirm that high dose C is not being used to treat coronavirus infection.”
What was shocking is that not a single Medical Officer of Health replied that IVC was being prescribed to those dying from coronavirus infection.
Another surprise was the reaction of Johns Hopkins one of the great hospitals of the world. Its distinguished professors were the first to introduce the value of bedside teaching for students. During this pandemic they were considered the authority in reporting the number of coronavirus deaths. So, I was shocked to receive this response, “We are not conducting clinical trials or administering C as a treatment for COVID 19.” And even Harvard Medical School where I spent so many years as a student and later training as a surgeon, never replied to me.
What is going to happen? It’s that the Chinese study will likely fail to end the controversy and patients will continue to die needlessly of this virus. I was hoping that one infectious expert, or Medical Officer of Health, would possess the intellectual curiosity to ask, “I wonder if high does IVC could save lives?” It’s tragic this has not occurred. Some would label this as medical ignorance, others as malpractice, or if a loved one has died as murder, and finally a court of law looking all the facts decide it’s been mass murder.
So, we have a unique situation. It’s been said that war is far too important to be left to generals. Due to the economic chaos caused by coronavirus this disaster may be much too important to be left to medical experts when so many North Americans have suffered.
It’s time for the government to demand that our medical schools conduct a study of IVC. There is no shortage of patients. We have the scientific talent in our universities. Vitamin C is inexpensive and will virtually never cause complications. Vitamin C has never killed anyone. Besides, this study could be done in a short time and not require thousands of patients.
Who will grasp the moment and save countless lives?
(Syndicated columnist W. Gifford-Jones, MD, (also known as Kenneth Walker, MD) graduated from Harvard Medical School in 1950. He did surgical residencies at McGill University, the University of Rochester, and Harvard Medical School. Still an activist, his website is http://www.docgiff.com.)
(The views expressed in this article are the author’s and not necessarily that of all members of the Orthomolecular Medicine News Service Editorial Review Board. OMNS welcomes discussion on a variety of subjects. Readers may submit their own article drafts to the Editor at the contact email below.)
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana) Ilyès Baghli, M.D. (Algeria) Ian Brighthope, MBBS, FACNEM (Australia) Gilbert Henri Crussol, D.M.D. (Spain) Carolyn Dean, M.D., N.D. (USA) Ian Dettman, Ph.D. (Australia) Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom) Ron Erlich, B.D.S. (Australia) Hugo Galindo, M.D. (Colombia) Martin P. Gallagher, M.D., D.C. (USA) Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico) William B. Grant, Ph.D. (USA) Tonya S. Heyman, M.D. (USA) Suzanne Humphries, M.D. (USA) Ron Hunninghake, M.D. (USA) Robert E. Jenkins, D.C. (USA) Bo H. Jonsson, M.D., Ph.D. (Sweden) Felix I. D. Konotey-Ahulu, MD, FRCP, DTMH (Ghana) Jeffrey J. Kotulski, D.O. (USA) Peter H. Lauda, M.D. (Austria) Thomas Levy, M.D., J.D. (USA) Alan Lien, Ph.D. (Taiwan) Homer Lim, M.D. (Philippines) Stuart Lindsey, Pharm.D. (USA) Victor A. Marcial-Vega, M.D. (Puerto Rico) Charles C. Mary, Jr., M.D. (USA) Mignonne Mary, M.D. (USA) Jun Matsuyama, M.D., Ph.D. (Japan) Joseph Mercola, D.O. (USA) Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico) Karin Munsterhjelm-Ahumada, M.D. (Finland) Tahar Naili, M.D. (Algeria) W. Todd Penberthy, Ph.D. (USA) Selvam Rengasamy, MBBS, FRCOG (Malaysia) Jeffrey A. Ruterbusch, D.O. (USA) Gert E. Schuitemaker, Ph.D. (Netherlands) T.E. Gabriel Stewart, M.B.B.CH. (Ireland) Thomas L. Taxman, M.D. (USA) Jagan Nathan Vamanan, M.D. (India) Garry Vickar, M.D. (USA) Ken Walker, M.D. (Canada) Raymond Yuen, MBBS, MMed (Singapore) Anne Zauderer, D.C. (USA) Andrew W. Saul, Ph.D. (USA), Editor-In-Chief Associate Editor: Robert G. Smith, Ph.D. (USA) Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan) Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA) Editor, French Edition: Vladimir Arianoff, M.D. (Belgium) Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway) Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt) Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea) Assistant Editor: Helen Saul Case, M.S. (USA) Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA) Legal Consultant: Jason M. Saul, JD (USA)
Comments and media contact: firstname.lastname@example.org OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.